Publications by authors named "Gregory Everson"

Claim this Profile
T
The Cholate Challenge Test Quantified Baseline Functional Heterogeneity and Improvement in Response to Resmetirom in MASH-related Child-Pugh A Cirrhosis.
Naim Alkhouri, Michael P McRae, Rebecca Taub, Brandon Hill, Joanne C Imperial, Gregory T Everson

Gastro Hep Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: Enhancing the Diagnostic Performance of the Oral Cholate Challenge Test: Implications for Avoidance of Potentially Unnecessary Endoscopy.
Tarek Hassanein, Andrew P Keaveny, Parvez Mantry, Mitchell Shiffman, Michael Leise, Gregory T Everson

Aliment Pharmacol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the performance of a dual-sample oral cholate challenge test: The HepQuant DuO test.
Michael P McRae, Touraj Shokati, Uwe Christians, Steve M Helmke, Gregory T Everson

Clin Chim Acta· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rencofilstat Treatment Improves Liver Function in MASH With Advanced Fibrosis as Quantified by HepQuant DuO.
Stephen A Harrison, Patrick Mayo, Todd Hobbs, Caroline Zhao, Carlos Canizares, Gregory T Everson

Liver Int· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the risk of clinical adverse events (RISK ACE) by quantifying liver function: A patient-centric model.
John Kittelson, Michael P McRae, Gregory T Everson

Eur J Intern Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT-V Study.
Mitchell Shiffman, K Rajender Reddy, Michael D Leise, Kamran Qureshi, Alastair D Smith, Gregory T Everson

Aliment Pharmacol Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Validated LC-MS/MS Assay for the Quantification of Cholate Isotopes in Human Serum.
Steve M Helmke, Michael P McRae, Uwe Christians, Touraj Shokati, Gregory T Everson

J Appl Lab Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of an oral cholate challenge test for the management of patients at risk for large esophageal varices.
Shailesh Chavan, Michael P McRae, Kelly R Pitts, Gregory T Everson

PLoS One· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic improvement within 27 days of avenciguat treatment in Child-Pugh A cirrhosis detected by an oral cholate challenge test.
Eric J Lawitz, Judith Ertle, Corinna Schoelch, Isabella Gashaw, Michael P McRae, Gregory T Everson

Liver Transpl· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Reading the cholate-A new gateway to portal hypertension and oesophageal varices: Authors' reply.
Tarek Hassanein, Andrew P Keaveny, Parvez Mantry, Alastair D Smith, Michael P McRae, Gregory T Everson

Aliment Pharmacol Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic Dysfunction Quantified by HepQuant DuO Outperforms Child-Pugh Classification in Predicting the Pharmacokinetics of Ampreloxetine.
Jitendra Kanodia, Hugh Giovinazzo, Wayne Yates, David L Bourdet, Michael P McRae, Gregory T Everson

Clin Pharmacol Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices.
Tarek Hassanein, Andrew P Keaveny, Parvez Mantry, Alastair D Smith, Michael P McRae, Gregory T Everson

Aliment Pharmacol Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Oral Cholate Challenge Test Quantifies Risk for Liver-Related Clinical Outcomes in Primary Sclerosing Cholangitis.
Steve Helmke, John Kittelson, Joanne C Imperial, Michael P McRae, Gregory T Everson

Gastro Hep Adv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Within-individual reproducibility of a dual sample oral cholate challenge test (DuO) and simplified versions of the HepQuant SHUNT test.
Michael P McRae, John Kittelson, Steve M Helmke, Gregory T Everson

Clin Transl Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic Elevation of Aromatic Amino Acids in Hepatitis C Virus-Induced Cirrhosis After a Standard Meal.
Kareen L Hill, James A Haddad, Rabab O Ali, Grace Y Zhang, Gabriella M Quinn, Gregory T Everson

Clin Transl Gastroenterol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in noninvasive measurement of liver function and physiology: The HepQuant DuO test.
Michael P McRae, John Kittelson, Steve M Helmke, Gregory T Everson

Basic Clin Pharmacol Toxicol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compartmental model describing the physiological basis for the HepQuant SHUNT test.
Michael P McRae, Steve M Helmke, James R Burton, Gregory T Everson

Transl Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease.
Amanda Wieland, Ohad Etzion, Rabab O Ali, Elliot Levy, David E Kleiner, Gregory T Everson

Clin Gastroenterol Hepatol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The within-individual reproducibility of the disease severity index from the HepQuant SHUNT test of liver function and physiology.
James R Burton, Steven Helmke, Shannon Lauriski, John Kittelson, Gregory T Everson

Transl Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting clinical decompensation in patients with cirrhosis using the Hepquant-SHUNT test.
Mohammad Amin Fallahzadeh, Daniel J Hansen, James F Trotter, Gregory T Everson, Giovanna Saracino

Aliment Pharmacol Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: stratifying risk of adverse outcomes in cirrhosis-the Hepquant SHUNT test. Authors' reply.
Sumeet K Asrani, Gregory T Everson

Aliment Pharmacol Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation.
Elizabeth C Verna, Marina Serper, Jaime Chu, Kathleen Corey, Oren K Fix, Gregory T Everson

Hepatology· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation.
James R Burton, Norah A Terrault, David S Goldberg, Roy D Bloom, Richard Gilroy, Gregory T Everson

Transplantation· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test.
Alexander Lemmer, Lisa VanWagner, Zaira Gasanova, Steve Helmke, Gregory T Everson

Congenit Heart Dis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT Study.
Ira M Jacobson, Fred Poordad, Roberto Firpi-Morell, Gregory T Everson, Elizabeth C Verna

Clin Transl Gastroenterol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis